Dr. Marco Andre B Rodrigues Maricevich, MD

Dr. Maricevich practices at Baylor St. Luke's Medical Center in Houston, Texas, part of CommonSpirit Health.

Dr. Maricevich's NPI, 1417150228, was assigned on June 8, 2007. Dr. Maricevich graduated from Federal University of Pernambuco Faculty of Medicine in 2004. Dr. Maricevich holds Texas license Q70773.

Dr. Maricevich's primary practice is Baylor St. Luke's Medical Center, at 6720 Bertner Ave, STE Mc1-266, Houston, TX 77030 in Harris County. The practice phone is (832) 355-1000.

Dr. Maricevich's primary practice is Baylor St. Luke's Medical Center in Houston, Texas, part of CommonSpirit Health. Dr. Maricevich is also affiliated with The University of Texas MD Anderson Cancer Center. The medical group on file is Baylor Medicine. Dmand AI also links Dr. Maricevich to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Maricevich practices, 4 sites in all. Vendor and product names are available with a free account.

Plastic and reconstructive surgery is Dr. Maricevich's primary specialty in the NPI Registry, under taxonomy code 2086S0122X. Dr. Maricevich is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. Maricevich's licenses on file in 3 states: Texas, Minnesota and Wisconsin.

Dmand AI lists breast surgery among the conditions Dr. Maricevich treats.

CMS data shows 15 Medicare services from Dr. Maricevich across 1 procedure code in 2022, all of them office visits, for 30 Medicare patients. Medicare paid $1,316 for them. Every service was in an office.

CMS counts 30 Medicare patients who saw Dr. Maricevich in 2024. The largest group is 65 to 74, with 16 patients. 75% of them have high blood pressure, and 67% have high cholesterol. Their average risk score is 2.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Maricevich's median patient age at 50, with 85% women.

In 2024, Dr. Maricevich wrote 18 Medicare Part D claims for 12 patients. 100% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $37 in total drug cost. In 2020, CMS named 15 claims across 1 drug.

Dr. Maricevich accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 14 procedures of melanoma (skin cancer) excision by Dr. Maricevich, more than 69% of the clinicians it reports for that procedure.

Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 35 papers to Dr. Maricevich, published from 2008 to 2024. 2022 was the busiest year, with 6. The most frequent topics are Postoperative Complications, Free Tissue Flaps and Plastic Surgery Procedures. Dr. Maricevich has published most often in Plast Reconstr Surg. Dr. Maricevich's most frequent co-authors are Amjed Abu-Ghname, MD, Renata Lins Bezerra Desouza Maricevich, MD and Sebastian Winocour, MD.

CMS Open Payments shows 26 general payments to Dr. Maricevich from 14 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 60% of the total. Cook Medical LLC paid the most, $2,000.

Dr. Maricevich graduated from Federal University of Pernambuco Faculty of Medicine in 2004. Dr. Maricevich is a member of ACS.

Dr. Maricevich is in network with 20 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.